Back
Citius Pharmaceuticals Vs. Agilent Technologies Industry Stock Comparison
Sell
31
CTXR
Citius Pharmaceuticals
Last Price:
0.33
Seasonality Move:
21.66%
Sell
39
A
Agilent Technologies
Last Price:
130.21
Seasonality Move:
8.09%
Sell
31
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.33. The Score for CTXR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Agilent Technologies (A)
is a Sell
Is Agilent Technologies a Buy, Sell or Hold?
- The current Agilent Technologies [A] share price is $130.22. The Score for A is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- A is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
A Stock Price Chart
What is Agilent Technologies's stock price today?
-
The Agilent Technologies share price today is $130.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and A is experiencing selling pressure, which indicates risk of future bearish movement.
CTXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 39.61 | Sell |
| Chaikin Money Flow: | 1360852 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.35 - 0.41) | Sell |
| Bollinger Bands (100): | (0.39 - 0.77) | Sell |
A Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.52 | Sell |
| Relative Strength Index (14 RSI): | 37.59 | Sell |
| Chaikin Money Flow: | -1912561 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (131.57 - 140.83) | Sell |
| Bollinger Bands (100): | (131.77 - 142.47) | Sell |
CTXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.39 | Sell |
| 20-day SMA: | 0.38 | Sell |
| 50-day SMA: | 0.44 | Sell |
| 200-day SMA: | 0.65 | Sell |
| 8-day EMA: | 0.39 | Sell |
| 20-day EMA: | 0.39 | Sell |
| 50-day EMA: | 0.45 | Sell |
| 200-day EMA: | 0.63 | Sell |
A Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 135.82 | Sell |
| 20-day SMA: | 134.53 | Sell |
| 50-day SMA: | 138.94 | Sell |
| 200-day SMA: | 138.6 | Sell |
| 8-day EMA: | 134.26 | Sell |
| 20-day EMA: | 135.78 | Sell |
| 50-day EMA: | 137.53 | Sell |
| 200-day EMA: | 136.53 | Sell |
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Agilent Technologies Earnings Growth & A Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.42 per share.
Citius Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agilent Technologies Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||